...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: The MD@A for the period ending July 31, 2017

Yes, I admit I was being conservative in my market cap estimates and also basing my statements on current float and not projecting future dilution. Also, I was just factoring in BETonMACE. Between now and top-line of BETonMACE, there may also be positive renal trial(s) results and positive Fabry/other orphan trial results. So the ceiling is much higher for sure.

BearDownAZ

Share
New Message
Please login to post a reply